How Psychedelic Research Will Transform Mental Health Treatment
Robert Jesse is convenor of the Council on Spiritual Practices. Through CSP, he was instrumental in creating the psilocybin research team at the Johns Hopkins University, and he is one of its co-investigators. He also lead the writing of an amicus brief for the U.S. Supreme Court in a key religious liberty case. The Court’s 8-0 decision upheld the right of a church, the União do Vegetal, to its sacrament containing the controlled substance DMT. Prior to CSP, he worked as a consultant in information technology for AT&T Bell Labs and others, then in several capacities for Oracle Corporation, lastly as a vice president of business development. His university training is in computer science and electrical engineering.
Charles S. Grob, M.D., is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He conducted the first government-approved study of MDMA, and was the principal investigator of an international biomedical psychiatric research projectin the Brazilian Amazon of the plant, ayahuasca. He is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients. Dr. Grob has published numerous articles in medical and psychiatric journals and collected volumes, and is the editor of Hallucinogens: A Reader. He is a founding board member of the Heffter Research Institute.
Joe Green is a serial social entrepreneur and investor who has been a pioneer in the intersection between technology and community organizing. Joe is a native and huge fan of LA, and has returned home recently to co-found Treehouse, which is building the first ground up co-loving building in Los Angeles. Joe previously co-founded Causes, NationBuilder, and FWD.us. Joe is passionate about integrating mystical experiences into community and culture.